CAMP4 Therapeutics Corporation Common Stock vs. Johnson & Johnson
CAMP
CAMP4 Therapeutics Corporation Common Stock
$4.48 -0.22%
VS JNJJohnson & Johnson
$275.30 -1.12%
Johnson & Johnson (JNJ) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| CAMP | JNJ | |
|---|---|---|
| Market Cap | $281.76 million | $670.99 billion |
| Revenue (TTM) | $4.22 million | $97.93 billion |
| Net Income (TTM) | $-107,244,000 | $21.04 billion |
JNJ leads on 3 of 3 size & scale factors.
Valuation
| CAMP | JNJ | |
|---|---|---|
| P/E Ratio | — | 31.94 |
| Price / Book | -406.58 | 7.90 |
| Price / Sales | 66.83 | 6.85 |
CAMP and JNJ split the valuation factors evenly.
Profitability
| CAMP | JNJ | |
|---|---|---|
| Net Margin | -2543.74% | 21.48% |
| Return on Equity | 15475.32% | 24.76% |
CAMP and JNJ split the profitability factors evenly.
Dividend
| CAMP | JNJ | |
|---|---|---|
| Dividend Yield | — | 1.95% |
| Payout Ratio | — | 62.18 |
CAMP and JNJ split the dividend factors evenly.
Risk & Sentiment
| CAMP | JNJ | |
|---|---|---|
| Short Interest | 2.82% | 0.67% |
JNJ leads on 1 of 1 risk & sentiment factors.
Dig deeper: CAMP overview, CAMP financials, JNJ overview, JNJ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.